|
Oct 9
|
Trinity Biotech PLC (TRIB) Q2 2024 Earnings Call Highlights: Strong Point-of-Care Growth Amidst ...
|
|
Oct 8
|
Trinity Biotech Shares Surge on Positive Pre-Pivotal Clinical CGM Trial
|
|
Oct 7
|
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
|
|
Sep 26
|
Trinity Biotech Acquires Preeclampsia Prediction Firm
|
|
Sep 25
|
Trinity Biotech's Stock Rises After Acquisition of Metabolomics
|
|
Sep 24
|
Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market
|
|
Jun 24
|
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor
|
|
May 23
|
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
|
|
May 21
|
Trinity Biotech plc to Announce Q1 2024 Financial Results
|
|
May 16
|
Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
|
|
May 13
|
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales
|
|
May 8
|
Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development
|
|
Apr 8
|
Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript
|
|
Apr 5
|
Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...
|
|
Apr 4
|
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
|
|
Mar 28
|
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
|
|
Mar 8
|
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
|
|
Mar 6
|
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
|
|
Feb 8
|
Trinity Biotech to Present at Emerging Growth Conference
|
|
Feb 7
|
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
|